AVGO Shares Drop 13% Post Q2 Results: Buy, Sell or Hold on the Dip?

Broadcom shares fell 12.6% after fiscal Q2 2026 results despite revenue beating the Zacks Consensus Estimate by 0.68% and EPS beating by 1.67%. Investors were disappointed by guidance and the absence of a meaningful lift to the longer-term AI outlook, even though Broadcom raised fiscal 2026 AI semiconductor revenue guidance to $56 billion and reiterated expectations for more than $100 billion in AI revenues in fiscal 2027.

Analysis

The market is signaling that the issue is not execution but durability of the AI growth curve. A sharp post-earnings de-rating after a clean beat usually means the stock had become a proxy for “AI monetization acceleration,” and management’s incremental outlook failed to extend that narrative; that creates a valuation air pocket because multiple compression can outlast fundamentals by 1-2 quarters.

Second-order, this is more relevant for the AI supply chain than the company itself: if the market starts demanding evidence of accelerating order cadence rather than just strong current bookings, hyperscaler capex beneficiaries with more linear demand visibility may absorb flows from AVGO. It also pressures other semis exposed to AI networking and custom silicon to prove that 2027 revenue targets are not just aspirational, because investors will now discount far-out AI forecasts more heavily.

The main risk is that consensus may be overfitting one guidance print to a multi-year AI buildout. If AI capex re-accelerates into the next two quarters, the stock could recover quickly because the selloff resets expectations and improves entry valuation; the reversal catalyst would be any evidence of backlog conversion, design-win expansion, or a larger-than-expected step-up in AI revenue contribution at the next print. The time horizon matters: near term, sentiment and positioning can keep pressure on the shares; over months, fundamentals could reassert if the AI roadmap remains intact.

The contrarian read is that the market may be punishing the absence of upside revision more than any actual deterioration. That often creates the best entry when the company is still raising the floor, not cutting it; if AI revenue visibility is credible, the current drawdown may be more about a crowded ownership reset than a thesis break. Still, the burden of proof has shifted to management to convert long-dated TAM claims into nearer-term cadence.

Key Decisions for Investors

• Avoid adding to AVGO immediately; wait 3-5 trading days for post-earnings de-risking to clear before considering a long entry, since valuation compression can persist even after the first bounce.
• For a tactical bearish expression, buy 1-2 month AVGO put spreads into any relief rally; risk/reward is favorable if the stock fails to reclaim its pre-earnings gap and implied volatility cools.
• Pair trade: long a more visible AI capex beneficiary, short AVGO, for 4-8 weeks to isolate ‘visibility premium’ versus ‘long-duration AI story’ risk; this works if the market keeps rewarding nearer-term revenue conversion.
• If holding AVGO, use the selloff to overwrite downside with covered calls 6-10% OTM over the next quarter; the goal is to monetize elevated sentiment risk while retaining upside if the AI narrative reaccelerates.
• Set a catalyst trigger on the next hyperscaler capex commentary cycle; if peers confirm accelerating AI networking demand, revisit long AVGO aggressively because the current move likely overshot the fundamental disappointment.